{
    "organizations": [],
    "uuid": "bbe731c9add2cce5670654432d227af590417239",
    "author": "",
    "url": "https://www.reuters.com/article/brief-medicure-places-prexxartan-oral-so/brief-medicure-places-prexxartan-oral-solution-project-on-hold-idUSFWN1R10HK",
    "ord_in_thread": 0,
    "title": "BRIEF-Medicure Places PREXXARTAN Oral Solution Project On Hold",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 39 AM / Updated 6 minutes ago BRIEF-Medicure Places PREXXARTAN Oral Solution Project On Hold Reuters Staff 1 Min Read March 19 (Reuters) - Medicure Inc: * MEDICURE - PLACED PREXXARTAN ORAL SOLUTION PROJECT ON HOLD PENDING RESOLUTION OF DISPUTE BETWEEN OWNER OF NDA, CARMEL BIOSCIENCES, OTHERS Source text for Eikon: Further company coverage:",
    "published": "2018-03-19T13:38:00.000+02:00",
    "crawled": "2018-03-19T13:47:22.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "place",
        "prexxartan",
        "oral",
        "solution",
        "project",
        "hold",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "medicure",
        "inc",
        "medicure",
        "placed",
        "prexxartan",
        "oral",
        "solution",
        "project",
        "hold",
        "pending",
        "resolution",
        "dispute",
        "owner",
        "nda",
        "carmel",
        "bioscience",
        "others",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}